Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Hospitals permitted to...

    Hospitals permitted to add trade margin on orthopaedic knee implants: NPPA Clarification

    Farhat NasimWritten by Farhat Nasim Published On 2019-08-31T14:37:01+05:30  |  Updated On 31 Aug 2019 2:37 PM IST
    Hospitals permitted to add trade margin on orthopaedic knee implants: NPPA Clarification

    This clarification comes after the NPPA was informed about certain Third Party Administrators (TPAs) who are not allowing trade margins to Hospitals, Nursing Homes, Clinic on orthopaedic knee implants as per the rates prescribed by NPPA earlier this month.


    New Delhi: Providing clarity on the matter of trade margins, the country’s apex drug price regulator, the National Pharmaceutical Pricing Authority (NPPA) has explained that Hospitals, Nursing Homes and Clinics are permitted to add trade margin on orthopaedic knee implants.


    Also Read: Government extends caps price of knee implants for one more year


    This clarification comes after the NPPA was informed about certain Third Party Administrators (TPAs) are not allowing trade margins to Hospitals, Nursing Homes, Clinic on orthopaedic knee implants as per the rates prescribed by NPPA earlier this month.


    It has been earlier reported that the maximum retail price (MRP) of orthopaedic knee implants would be monitored to make sure that the cost does not increase beyond 10 per cent in a given year.


    Also Read: Cost of orthopaedic knee implants will not be allowed to rise beyond 10 percent: NPPA


    Addressing the hinderence, NPPA stated that the ceiling prices specified in the notice are inclusive of trade margin and stated;




    It is, therefore, clarified that as per Note (r) of the aforesaid Notification, Hospitals/Nursing Homes/Clinics are allowed to add trade margins on orthopedic knee implants as per the rates prescribed in the aforesaid notifications subject to the overall limits of the ceiling It is further clarified that the ceiling prices specified in the aforesaid notifications are inclusive of trade margin.



    Medical Dialogues had earlier reported that the government had capped prices of knee implants at a significantly lower rate than current market rates, a move that could result in savings of Rs 1,500 crore annually to patients requiring surgery.


    Also Read: Knee Surgery Implants now under Price Ceiling, Effective Immediately

    clinicsconsumer savingDPCODrugs Prices Control Ordergovt of indiaHealthcarehospitalsimplant devicesknee implantknee implant costknee implant mrpknee implant noticeNational Pharmaceutical Pricing AuthorityNPPAnursing homesorthopaedic implantprice capThird Party AdministratorsTPAs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok